Newsfeeds - Spark Newswire

1 minute read

Twitter To $50? Here Are 5 Other Price Target Changes For Wednesday

Today, 6:17 PM

Wedbush boosted the price target on Twitter, Inc. (NYSE: TWTR) from $30 to $50. Wedbush analyst Daniel Ives maintained the stock with a Neutral rating. Twitter shares rose 3.4% to $44.29 in pre-market trading.

AKAM

1 minute read

HC Wainwright & Co. Maintains Buy on BioNTech, Lowers Price Target to $272

By Benzinga Newsdesk

Today, 6:17 PM

HC Wainwright & Co. analyst Robert Burns maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the price target from $283 to $272.

BNTX

2 minute read

BioNTech Whale Trades For August 09

By Benzinga Insights

Today, 6:17 PM

A whale with a lot of money to spend has taken a noticeably bullish stance on BioNTech. Looking at options history for BioNTech (NASDAQ:BNTX) we detected 10 strange trades.

BNTX

7 minute read

Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday

By Lisa Levin

Today, 6:17 PM

Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.

AIHS

1 minute read

Fear & Greed Index Remains In ‘Neutral’ Zone As Investors Await Wednesday’s Inflation Report

By Lisa Levin

Today, 6:17 PM

The U.S. stock markets remained in the "neutral" zone on Tuesday, according to the CNN Money Fear and Greed index. Wall Street closed mixed on Friday after a New York Federal Reserve survey showed U.S. consumers' expectations declining sharply in July.

BNTX

1 minute read

Here’s What’s Going On With Novavax Shares

By Henry Khederian

Today, 6:17 PM

Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 3.05% to $58.43 Monday afternoon in sympathy with BioNTech SE - ADR (NASDAQ: BNTX), which reported worse-than-expected second-quarter results.

BNTX

1 minute read

Why Moderna Shares Are Falling Following BioNTech’s Earnings Results

By Henry Khederian

Today, 6:17 PM

Moderna Inc (NASDAQ: MRNA) shares are trading lower by 2.32% to $182.50 Monday afternoon in sympathy with BioNTech SE - ADR (NASDAQ: BNTX), which reported worse-than-expected second-quarter results.

BNTX

2 minute read

Why These Pfizer Analysts Like The Global Blood Therapeutics Deal

By Wayne Duggan

Today, 6:17 PM

Pfizer Inc. (NYSE: PFE) shares were trading lower Monday after the drugmaker announced a $5.4-billion bid to acquire blood disorder drugmaker Global Blood Therapeutics Inc (NASDAQ: GBT).

BHVN

2 minute read

Genmab and BioNTech Expand Global Collaboration To Include Development Of Monospecific Antibody Candidates To Address Malignant Solid Tumors

By Bill Haddad

Today, 6:17 PM

Collaboration expands to include development of monospecific antibody candidates to address malignant solid tumors Expanded collaboration leverages Genmab's proprietary HexaBody® technology platform to

BNTX

1 minute read

Here’s Why BioNTech Stock Is Moving

By Henry Khederian

Today, 6:17 PM

BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher in sympathy with Moderna Inc (NASDAQ: MRNA), which reported better-than-expected second-quarter results.

BNTX